Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Abbott Australasia Pty Ltd Molecular Division

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (29)
Cancellation by sponsor (9)
COVID-19 test kit (3)

Date

2024 (2)
2023 (2)
2022 (3)
2021 (1)
2020 (11)
2019 (2)
2015 (4)
2014 (9)
2013 (4)
2012 (3)

Results for "[search-keyword]"

Search

Sponsor content

41 result(s) found, displaying 11 to 20

Abbott Australasia Pty Ltd Molecular Division - Human immunodeficiency virus (HIV) IVDs Cancelled under Section 41GL(d) of the Act

10 June 2021

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Abbott Australasia Pty Ltd Molecular Division - Human papilloma virus IVDs (324193)

27 September 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Molecular Division - Human papilloma virus IVDs.
Abbott Australasia Pty Ltd Molecular Division - General laboratoryware IVDs (319067)

19 June 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Molecular Division - General laboratoryware IVDs.
Abbott Australasia Pty Ltd Molecular Division - Inborn/inherited genetic disorder IVDs Cancelled under Section 41GL(d) of the Act

14 September 2020

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Abbott Australasia Pty Ltd Molecular Division - Inborn/inherited genetic disorder IVDs Cancelled under Section 41GL(d) of the Act

14 September 2020

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Abbott Australasia Pty Ltd Molecular Division - Human immunodeficiency virus (HIV) IVDs Cancelled under Section 41GL(d) of the Act

14 September 2020

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Abbott Australasia Pty Ltd Molecular Division - Interpretive software IVDs Cancelled under Section 41GL(d) of the Act

14 September 2020

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Abbott Australasia Pty Ltd Molecular Division - Multiple-fungi IVDs Cancelled under Section 41GL(d) of the Act

14 September 2020

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Abbott Australasia Pty Ltd Molecular Division - Mycobacteria IVDs Cancelled under Section 41GL(d) of the Act

14 September 2020

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Molecular Division
Alinity m SARS-CoV-2 AMP Kit

27 August 2020

COVID-19 test kit

Nucleic Acid Test - Intended for use: Laboratory.

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.